Search | Clinical Trials Finder

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:06 AM EDT

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 1,548 matching trials from the local directory fallback.

Filters: Intervention: PRE Clear all

Conditions: Chronic Subdural Hematoma, Hemorrhage Brain
Interventions: Matched pair Aristotle 14 guidewire and Plato 17 microcatheter, Surgeon combination preference; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Alzheimer Disease, Hydrocephalus
Interventions: MR brain, MRI screening form, Urine pregnancy test; Diagnostic Test · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Breast Cancer
Interventions: Modification to Pre-operative Order Set; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1,896 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Chronic Widespread Pain, Fibromyalgia (FM), Lupus
Interventions: Emotional Awareness and Expression Therapy (EAET); Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Spinal Cord Injuries, Transverse Myelitis
Interventions: expressive writing; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obstructive Sleep Apnea
Interventions: Motivational Enhancement Therapy, Positive Airway Pressure (PAP) therapy; Behavioral · Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 100 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pregnancy
Interventions: Prenatal Capsule, Prenatal Gummy; Dietary Supplement
Lead sponsor: Perelel Inc.; Industry
Eligibility: 21 Years to 40 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Buprenorphine Dependence, Opioid Use, Unspecified, Opioid-use Disorder
Interventions: DNA/Genetic/Pharmacokenetic Blood Draws, Fetal & Neonatal MRI, Subutex / Buprenorphine; Diagnostic Test · Drug
Lead sponsor: Senthil Sadhasivam; Other
Eligibility: 18 Years and older · Female only
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Placental Insufficiency, Stillbirth
Interventions: Data Collection Throughout Pregnancy and Delivery; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Breast Cancer, Prostate Cancer
Interventions: Opt Out of Questionnaire, Pre & Post Surveys; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cognitive Decline, Depression
Interventions: Active Control, Therapist-Assisted Internet Cognitive-Behavioral Therapy for Depression; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 50 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Acute Kidney Injury, Contrast Induced Nephropathy, Coronary Angiography, Heart Failure, Percutaneous Coronary Intervention
Interventions: Remote ischemic preconditioning, Sham remote ischemic conditioning; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania • Dallas, Texas • Richmond, Virginia

Conditions: Autism Spectrum Disorder, Communication Disabilities, Communication, Nonverbal, Intellectual Disability, Self-Injurious Behavior
Interventions: NonPrefFCT, PrefFCT; Behavioral
Lead sponsor: Joel E. Ringdahl; Other
Eligibility: 2 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 2
States / cities: Athens, Georgia • Iowa City, Iowa

Conditions: Prostate Cancer, Prostate Cancer Metastatic
Interventions: Abiraterone Acetate, Prednisone; Drug
Lead sponsor: Martha Mims; Other
Eligibility: 18 Years and older · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2038
U.S. locations: 3
States / cities: Houston, Texas

Conditions: Aging, Healthy
Interventions: Elamipretide will be supplied as a sterile 5.0 mL single-patient, multi-dose glass vial containing 3.75 mL of elamipretide solution (elamipretide [80 mg/mL], phosphate buffer, and benzyl alcohol); Drug
Lead sponsor: David Marcinek; Other
Eligibility: 65 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Overweight and Obesity
Interventions: 24-hour ambulatory blood pressure, Liberal salt diet; Diagnostic Test · Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Allogeneic Transplantation
Interventions: Exercise Program (Cohort A Prehab), Exercise Program (Cohort B Rehab); Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 60 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alcohol Use Disorder (AUD), PTSD
Interventions: CBT + expressive writing, Wait-List Control; Behavioral
Lead sponsor: University of Rhode Island; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Frailty, Lobectomy, Lung Surgery, Pneumonectomy; Status, Prehabilitation, Segmentectomy, Thoracic, Wedge Resection
Interventions: Auricular Acupressure; Other
Lead sponsor: University of Chicago; Other
Eligibility: 50 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Stress Reaction
Interventions: Physical Presence with Reassurance, iCOVER; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 50 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 5
States / cities: Belmont, Massachusetts • Worcester, Massachusetts • Detroit, Michigan + 2 more

Conditions: Cancer, Cancer-Related Condition, Infertility
Interventions: Testicular tissue cryopreservation; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 0 Years to 17 Years · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2030
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Pregnancy
Interventions: Investigational MRI coil designed for pregnant women, MRI Scan; Device · Procedure
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Multiple Myeloma
Interventions: biologic sample preservation procedure, clonality analysis, fluorescence spectroscopy, laboratory biomarker analysis, polymerase chain reaction, protein analysis, quality-of-life assessment; Other · Genetic · Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2040
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Contact Lens Comfort
Interventions: Precision 7 contact lenses; Device
Lead sponsor: Southern College of Optometry; Other
Eligibility: 18 Years to 40 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Memphis, Tennessee

Search by objective public record fields.

Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center

MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)

The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

Community Health Advocates for Motivating PAP Use in Our Neighborhoods.

Prenatal Study in Healthy Pregnant Women

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes

Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Attenuating DEPression With Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU)

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

Harnessing Communication Preferences

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

Study of Healthy Aging and Physical Function With Elamipretide

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Improve Outcomes for Older Allogeneic Transplant Recipients

Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building

Auricular Acupressure in Prehabilitation

Promoting Improved Functioning Among People Experiencing Stressful Situations

Testicular Tissue Cryopreservation in Children

Advanced Fetal Imaging - Phase II

Collection of Samples and Clinical Data From Patients With Amyloid Diseases

Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses